✦ LIBER ✦

Results from a phase II multicenter, double-blind placebo-controlled study of Del-1 (VLTS-589) for intermittent claudication in subjects with peripheral arterial disease

✍ Scribed by Paul Michael Grossman; Farrell Mendelsohn; Timothy D. Henry; James B. Hermiller; Marc Litt; Jorge F. Saucedo; Robert J. Weiss; David E. Kandzari; Neal Kleiman; R. David Anderson; Daniel Gottlieb; Ronald Karlsberg; Jeffery Snell; Krishna Rocha-Singh

Book ID: 116190869
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 159 KB
Volume: 153
Category: Article
ISSN: 1097-6744
DOI: 10.1016/j.ahj.2007.01.038

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomised, double blind, placebo-cont

A randomised, double blind, placebo-controlled study to determine the efficacy of immune modulation therapy in the treatment of patients suffering from peripheral arterial occlusive disease with intermittent claudication

✍ C. McGrath; R. Robb; A.J. Lucas; A.H.R. Stewart; C.L. Underwood; J.K. Horridge; 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 260 KB

A Randomised, Double Blind, Placebo-cont

A Randomised, Double Blind, Placebo-controlled Study to Determine the Efficacy of Immune Modulation Therapy in the Treatment of Patients Suffering from Peripheral Arterial Occlusive Disease with Intermittent Claudication

✍ C. McGrath; R. Robb; A.J. Lucas; A.H.R. Stewart; C.L. Underwood; J.K. Horridge; 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 151 KB

Regional angiogenesis with vascular endo

Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: a phase ii randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermittent claudication

✍ S. Rajagopalan; E.R. Mohler; R.J. Lederman 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 32 KB